RxDoctor Payments Data

Crystal Dreher

Nurse Practitioner · Amarillo, TXNPI 1578117461

Payments from drug & device makers

$2,896in general payments, 2019–2025

Across 172 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$787
  • AstraZeneca$773
  • Boehringer Ingelheim$259
  • Regeneron Healthcare Solutions, Inc.$211
  • Mylan Specialty L.p.$194
  • Insmed, Inc.$108
  • plus $565 from 14 others

What the payments were for

  • Food & beverage$2,896100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,896 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OfevNintedanib Esylate39$490,549
Trelegy ElliptaFluticasone/Umeclidin/Vilanter537$402,845
Breo ElliptaFluticasone/Vilanterol273$122,731
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr222$115,156
Breztri AerosphereBudesonide/Glycopyr/Formoterol109$72,608
Stiolto RespimatTiotropium Br/Olodaterol Hcl86$44,691
Spiriva RespimatTiotropium Bromide59$36,930
SymbicortBudesonide/Formoterol Fumarate107$31,917
Arnuity ElliptaFluticasone Furoate81$22,328
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate108$22,317
BreynaBudesonide/Formoterol Fumarate112$19,296
Incruse ElliptaUmeclidinium Bromide51$18,798
EliquisApixaban23$17,921
Albuterol Sulfate HfaAlbuterol Sulfate272$7,357
DuleraMometasone/Formoterol17$6,509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta$787$681,8571,164 claims
Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat, Striverdi Respimat$259$575,673198 claims
AstraZenecaBreztri Aerosphere, Symbicort$773$104,525216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Amarillo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →